ALETA BIOTHERAPEUTICS
Reorientation and re-establishment of CAR-T therapy
Aleta Biotherapeutics is an immuno-oncology company focused on transforming cell therapies to enable them to target a broad spectrum of cancer indications, including currently untreatable solid tumours.
CEO
Paul Rennert
INVESTED COMPANY
2021
DETAILS
Aleta Biotherapeutics
27 Strathmore Rd.
Natick MA USA 01760
News